Factors associated with teenage ecstasy use

References

• Adlaf EM, Paglia A, Ivis FJ, Ialomiteanu A. Nonmedical drug use among adolescent students: Highlights from the 1999 Ontario student drug use survey. Canadian Medical Association Journal 2000; 162(12)1677–1680
   Web of Science ®Google Scholar
• Baker A, Kochan N, Dixon J, Wodak A, Heather N. Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia. Drug and Alcohol Dependence 1994; 34: 155–160
   PubMed Web of Science ®Google Scholar
• Balding J. Young people in 2000, The health related questionnaire results for 42,073 young people between the ages of 10 and 15. Legal and illegal drugs. Exeter. Schools Health Education Unit. 2001
   Google Scholar
• Beck J, Rosenbaum M. Pursuit of ecstasy: The MDMA experience. State University of New York Press, Albany, NY 1994
   Google Scholar
• Beinart S, Anderson B, Lee S, Utting D. Youth at risk? A national survey of risk factors, protective factors and problem behavior among young people in England, Scotland and Wales. Communities that Care, London 2002
   Google Scholar
• Boeri MW, Sterk CE, Elifson KW. Rolling beyond the raves. Ecstays use outside the rave setting. Journal of Drug Issues 2004; 34: 831–860
   Web of Science ®Google Scholar
• Boys A, Lenton S, Norcross K. Poly drug use at raves by a Western Australian sample. Drug and Alcohol Review 1997; 16: 227–234
   PubMed Web of Science ®Google Scholar
• Burke J. Ecstasy deaths may have been caused by heat, not a bad batch. The Guardian June 30, 2001, Saturday, 30 June 2001
   Google Scholar
• Cassen R, Kingdon G. Tackling low educational achievement. Joseph Rowntree Foundation, York 2007
   Google Scholar
• Chesher GB. Designer drugs–the ‘whats’ and the ‘whys’. Medical Journal of Australia 1990; 153: 157–161
   PubMed Web of Science ®Google Scholar
• Christophersen AS. Amphetamine designer drugs–an overview and epidemiology. Toxicology Letters 2000; 112–113: 127–131
   PubMed Web of Science ®Google Scholar
• Clegg MT, Tracey JA. Ecstasy abuse in Ireland. Irish Medical Journal 1993; 86(4)118–120
   PubMedGoogle Scholar
• Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behaviour among a cohort of San Francisco men who have sex with men. Journal of Urban Health 2005; 82(1 Suppl. 1)i62–70
   PubMed Web of Science ®Google Scholar
• Curran VH. Is MDMA (‘Ecstasy’) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 2000; i42: 473–478
   Google Scholar
• DfES. The characteristics flow-attaining students. DfES, London 2005
   Google Scholar
• DfES/HM Treasury. Child poverty: Fair funding for schools: A review of the ways in which local authorities fund school to meet the costs arising from social deprivation among their pupils. DfES/HM Treasury, London 2005
   Google Scholar
• Degenhardt L, Barket B, Topp L. Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction 2004; 99: 187–195
   PubMed Web of Science ®Google Scholar
• Duff C. Party drugs and party people: Examining the ‘normalisation’ of recreational drug use in Melbourne, Australia. International Journal of Drug Policy 2005; 16: 161–170
   Web of Science ®Google Scholar
• Falck RS, Carlosn RG, Wang J, Siegal HA. Psychiatric disorders and their correlates among young adult MDMA users in Ohio. Journal of Psychoactive Drugs 2006; 38(1)19–29
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006; 101: 556–569
   PubMed Web of Science ®Google Scholar
• Forsyth AJM. Ecstasy and illegal drug design: A new concept in drug use. International Journal of Drug Policy 1997; 92(10)1317–1325
   Google Scholar
• Gamma A, Jerome L, Liechti ME, Sumnall HR. Is ecstasy perceived to be safe? A critical survey. Drug and Alcohol Dependence 2005; 77: 185–193
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, et al. Impaired cognitive performance in drug free users of recreational ecstays (MDMA). Journal of Neurology, Neurosurgery & Psychiatry 2000; 68: 719–725
   PubMed Web of Science ®Google Scholar
• Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL. The health effects of ecstasy: A literature review. Drug and Alcohol Review 2002; 21: 53–63
   PubMed Web of Science ®Google Scholar
• Grant BF. Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse 1996; 8: 195–210
   PubMedGoogle Scholar
• Green AR, Cross AJ, Goodwin GM. Review of the pharmacology of 3,4 methylenedioxymethamphetamine (MDMA or ecstasy). Psychopharmacology 1995; 119: 247–260
   PubMed Web of Science ®Google Scholar
• Guillot CR, Berman ME. MDMA (Ecstasy) use and psychiatric problems. Psychopharmacology 2007; 189: 575–576
   PubMed Web of Science ®Google Scholar
• Ghuran A, Nolan J. Recreational drug misuse: Issues for the cardiologist. Heart 2000; 83: 627–633
   PubMed Web of Science ®Google Scholar
• Handy C, Pates R, Barrowcliff A. Drug use in South Wales: Who uses ecstasy anyway?. Journal of Substance Misuse 1998; 3(8)82–88
   Google Scholar
• Henderson S. Drugs and culture: The question of gender. Drugs: Cultures, controls and everyday life, IN South. Sage Publications, London 1999
   Google Scholar
• Henry JA, Jeffrey's KL, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (‘Ecstasy’). Lancet 1992; 340: 384–387
   PubMed Web of Science ®Google Scholar
• Hibell B, Andersson B, Bjarnason T, Kokkevi A, Morgan M, Narusk A. The ESPAD report 1995: Alcohol and other drug use among students in 26 European countries. The Swedish Council for Information on Alcohol and Other Drugs, Stokholm 1995
   Google Scholar
• Hibell B, Andersson B, Ahlstrom S, Balakireva O, Bjarnason T, Kokkevi A, et al. The ESPAD report 1999: Alcohol and other drug use among students in 30 European countries. The Swedish Council for Information on Alcohol and Other Drugs, Stokholm 1999
   Google Scholar
• Hibell B, Andersson B, Bjarnason T, Balakireva O, Ahlstrom S, Kokkevi A, et al. The ESPAD report 2003: Alcohol and other drug use among studnets in 35 European countries. The Swedish Council for Information on Alcohol and Other Drugs, Stokholm 2003
   Google Scholar
• Huizink AC, Ferdinand RF, van der End F, Verhulst FC. Symptoms of anxiety and depression in childhood and use of MDMA: Prospective, population based study. British Medical Journal 2006; 332: 825–828
   PubMed Web of Science ®Google Scholar
• Johnston LD, O’Malley PM, Bachman JG. Rise in ecstasy use among American teens begins to slow 2001, Retrieved April 11, 2008 from (http://www.monitoringthefuture.org)
   Google Scholar
• Johnston J, Laslett AM, Jenkinson R, Miller P, Fry C. Victorian party drug trends 2003: Findings from the Party Drug Initiative (PDI). Technical Rep. No. 183, National Drug and Alcohol Research Centre, Sydney 2004
   Google Scholar
• Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. Canadian Medical Association Journal 2001; 165(7)917–928
   PubMed Web of Science ®Google Scholar
• Kandel D. Does marijuana use cause the use of other drugs?. Journal of the American Medical Association 2003; 289: 482–483
   PubMed Web of Science ®Google Scholar
• Kandel DD, Yamaguichi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. Journal of Studies on Alcohol 1992; 53: 447–457
   PubMed Web of Science ®Google Scholar
• Koesters SC, Greenberg JD, Pollack LM, Dolezal C. MDMA (‘ecstasy’) use with high risk behaviours, mental health, and other factors among gay/bisexual men in New York City. Drug and Alcohol Dependence 2002; 66: 115–125
   PubMed Web of Science ®Google Scholar
• Laws KR, Kokkalis J. Ecstasy (MDMA) and memory function: A meta-analytic update. Human Psychopharmacology 2007; 22: 381–388
   PubMed Web of Science ®Google Scholar
• Landry MJ. MDMA: A review of epidemiologic data. Journal of Psychoactive Drugs 2002; 34: 163–169
   PubMed Web of Science ®Google Scholar
• Leib R, Schuetz CG, Pfister H, von Sydow K, Wittchen H-U. Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug and Alcohol Dependence 2002; 68: 195–207
   PubMed Web of Science ®Google Scholar
• Lynskey MT, Heath A, C. Bucholz KD, Slutske WS, Madden PA, Nelson EC, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. Journal of the American Medical Association. 2003; 289: 427–433
   PubMed Web of Science ®Google Scholar
• Lynskey MT, Vink JM, Boomsma DI. Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behavior Genetics 2006; 36: 195–200
   PubMed Web of Science ®Google Scholar
• McCrystal P, Higgins K, Percy A, Thornton M. Emerging patterns in adolescent drug use in Northern Ireland: The Belfast Youth Development Study 2002. Child Care in Practice 2003; 9(1)73–83
   Google Scholar
• McCrystal P, Higgins K, Percy A. School exclusion drug use and delinquency in adolescence. Journal of Adolescence 2006; 29: 829–836
   PubMed Web of Science ®Google Scholar
• McCrystal P, Percy A, Higgins K. Frequent cannabis use among 14/15 year olds in Northern Ireland. Drug and Alcohol Dependence 2007a; 88: 19–27
   PubMed Web of Science ®Google Scholar
• McCrystal P, Percy A, Higgins K. Exclusion and marginalisation: The experience of school exclusion on drug use and antisocial behaviour. Journal of Youth Studies 2007b; 10(1)35–54
   Google Scholar
• Measham F, Aldridge J, Parker H. Dancing on drugs: Risk, health and hedonism in the British club scene. Free Association Books, London 2001
   Google Scholar
• Martins SS, Ghandour LA, Chilcoat HD. Pathways between ecstasy initiation and other drug use. Addictive Behaviors 2005; 21: 1511–1518
   Google Scholar
• Martins SS, Mazzzotti G, Chilcoat HD. Trends in ecstasy use in the USA from 1995 to 2001: Comparison with marijuana users and association with drug use. Experimental and Clinical Psychopharmacology 2007; 13(3)244–252
   Web of Science ®Google Scholar
• Moore D. ‘Speeding, ecking and tripping’: Ethnographic notes from a small world of psychostimulant use. Psychostimulant Use in Australia, D Burrows, B Flaherty, M MacEvoy. Australian Government Publishing Service, Canberra 1993; 71–90
   Google Scholar
• Morgan MJ. Memory deficits associated with recreational use of ‘ecstasy’ (MDMA). Psychopharmacology 1999; 141: 30–36
   PubMed Web of Science ®Google Scholar
• National Drug Strategy Household Survey. Western Australian results, 2000. 1998, http:www.wa.gov.au/drugres(aus). Retrieved: 9 March 2009
   Google Scholar
• NDM. Nationale Drugmonitor Jaarbericht (national drug monitor). Bureau, Utrecht 2002, Retrieved April 11, 2008 from www.trimbos.ni/default3698.html
   Google Scholar
• Panagopoulos I, Ricciardelli LA. Harm reduction and decision making among recreational ecstasy users. International Journal of Drug policy 2005; 16: 54–64
   Web of Science ®Google Scholar
• Parker H. Adolescent drug pathways in the 1990s. Tackling drugs together: One years on, J Braggins. Institute for the Study and Treatment of Delinquency, London 1997; 56–75
   Google Scholar
• Parker H, Aldridge J, Measham F. Illegal leisure: The normalization of adolescent recreational drug use. Routledge, London 1998
   Google Scholar
• Parrott AC. Human psychopharmacology of ecstasy (MDMA): A review of 15 years of empirical research. Human Psychopharmacology: Clinical and Experimental 2001; 16: 557–577
   PubMed Web of Science ®Google Scholar
• Parrott AC. Ecstasy: Very real, very damaging. The Psychologist 2002; 15(9)472–473
   Web of Science ®Google Scholar
• Patel MM, Wright DW, Ratcliff JJ, Miller MA. Shedding new light on the ‘safe’ club drug: Methylenedioxymethamphetamine (ecstasy), related fatalities. Academic Emergency Medicine 2004; 11: 208–210
   PubMed Web of Science ®Google Scholar
• PerKonigg A, Lieb R, Wittchen H-U. Prevalence of use, abuse and dependence in Germany: a review of selected epidemiological data. Eur. Addict. Res. 1998; 4(1–2)8–17
   PubMed Web of Science ®Google Scholar
• Peroutka SJ, Newman JH, Harris H. Recreational use of 3,4methylenedioxymethamphatamine (MDMA, ecstasy). Neuropsychopharmacology 1998; 1: 273–277
   Google Scholar
• Premier's Drug Prevention Council (PDPC). Victorian youth alcohol and drug survey 2003: Illicit drug findings. Premier's Drug Prevention Council, Melbourne 2004
   Google Scholar
• Raikos N, Tsoukali H, Psroulis D, Vassiliadis N, Tsoungas M, Njau SN. Amphetamine derivative related deaths in southern Greece. Forensic Science International 2002; 128(1–2)31–34
   PubMed Web of Science ®Google Scholar
• Randall T. ‘Rave’ scene, ecstasy use, leap atlantic. The Journal of American Medical Association 1992; 268: 1506–1514
   Web of Science ®Google Scholar
• Reid LW, Elifson KW, Sterk E. Ecstasy and gateway drugs: Initiating the use of ecstasy and other drugs. Annals of Epidemiology 2006; 17(1)74–90
   PubMed Web of Science ®Google Scholar
• Ricaurte GA, McCann UD. Neurotoxic amphetamine analogs: Effects in monkeys and implications for humans. Annals of the New York Academy of Sciences 1992; 68: 371–382
   Google Scholar
• Ricaurte GA. Adverse reactions with 3,4 methylenedioxymethamphetamine (MDMA, ecstasy). Drug Safety 1996; 15(2)107–115
   PubMed Web of Science ®Google Scholar
• Ricaurte GA, Yuan J, McCann DU. 3,4 methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity: Studies in aniamals. Neuropharmacology 2000; 151: 19–24
   Google Scholar
• Riley S, Hayward E. Patterns, trends and meanings of the drug use by dance users in Edinburgh, Scotland. Drugs: Education, Prevention and Policy 2004; 11(3)243–262
   Web of Science ®Google Scholar
• Rotheram-Borus MJ, Mann T, Chabon B. Amphetamine use and its correlates among youths living with HIV. AIDS Education and Prevention 1999; 11: 232–242
   PubMed Web of Science ®Google Scholar
• Saunders N. Ecstasy and the dance culture. Neals Yard Desktop Publishing, London 1995
   Google Scholar
• Schifano P, Di Furia L, Forza G, Minicuci N, Bricolo R. MDMA (‘ecstasy’) consumption in the context of polydrug abuse: A report on 150 patients. Drug and Alcohol Dependence 1998; 52: 85–90
   PubMed Web of Science ®Google Scholar
• Schifano F. Potential human neurotoxicity of MDMA (‘Ecstasy’): Subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies. Neuropschobiology 2000; 42: 25–33
   PubMed Web of Science ®Google Scholar
• Schifano F, Oyefesco A, Corkery J, Cobain K, Jambert-Gray R, Martinotti G, et al. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002. Human Psychopharmacology 2003; 18: 519–524
   PubMed Web of Science ®Google Scholar
• Schuster P, Leib R, Lamertz C, Wittchen HU. Is the use of ecstasy and hallucinogens increasing?. European Addiction Research 1998; 4: 75–82
   PubMed Web of Science ®Google Scholar
• Shewan D, Dalgarno P, Reith G. Perceived risk and risk reduction among ecstasy users: The role of drug, set and setting. International Journal of Drug Policy 2000; 10: 431–453
   Google Scholar
• Shuttleworth I. The relationship between social deprivation in Northern Ireland, as measured by free school eligibility and educational attainment at GCSE in Northern Ireland: A preliminary investigation. British Educational Research Journal 1995; 21(4)487–504
   Google Scholar
• Siegel RK. MDMA: Nonmedical use and intoxication. Journal of Psychoactive Drugs 1986; 18: 349–354
   PubMed Web of Science ®Google Scholar
• Singer LT, Linares TJ, Ntiri S, Henry R, Minnes S. Psychosocial profiles of older adolescent MDMA users. Drug and Alcohol Dependence 2004; 74: 245–252
   PubMed Web of Science ®Google Scholar
• Solowij N, Hall W, Lee N. Recreational MDMA use in Sydney: A profile of ‘ecstasy’ users and their experiences with the drug. British Journal of Addiction 1992; 87: 1161–1172
   PubMedGoogle Scholar
• Solowij N. Ecstasy (3,4-methylenedioxymethamphetamine). Current Opinion in Psychiatry 1993; 6: 411–415
   Google Scholar
• Stattin H, Kerr M. Parental monitoring: A reinterpretation. Child Development 2000; 71(4)1072–1085
   PubMed Web of Science ®Google Scholar
• Substance Abuse, and Mental Health Sevices Administration (SAMHSA). Results from the 2002 National Survey on Drug Use and Mental Health: National findings. MD: SAMHSA, Rockville 2003
   Google Scholar
• Topp L, Hando J, Dillon P, Roche A, Solouij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence 1999; 55: 105–115
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. Ecstasy and amphetamines: Global Survey 2003. UN Publication Sales No. E.03.XI.15, United Office on Drugs and Crime, United Nations, New York, NY/Vienna, Austria 2003
   Google Scholar
• van Ours J. Ecstasy and cocaine: Patterns of use among prime age individuals in Amsterdam. Addictive Behaviors 2005; 30: 1468–1473
   PubMed Web of Science ®Google Scholar
• Verke R, Gijsman H, Pieters M, Schoemaker R, de Visser S, Kuijpers M, et al. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 2001; 153: 196–202
   PubMed Web of Science ®Google Scholar
• Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and correlates of drug use and dependence in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry 1995; 52: 219–229
   PubMed Web of Science ®Google Scholar
• Webb E, Ashton CH, Kelly P, Kamali F. Alcohol and drug use in UK university students. Lancet 1996; 348: 922–925
   PubMed Web of Science ®Google Scholar
• White J, Bochner F, Irvine R. The agony of ‘ecstasy’: How can we avoid more ‘ecstasy’-related deaths?. The Medical Journal of Australia 1997; 166: 117–118
   PubMed Web of Science ®Google Scholar
• Wilkins C, Bhatta K, Pledger M, Casswell S. Ecstasy use in New Zealand: Findings from the 1998 and 2001 National Drug Surveys. The New Zealand Medical Journal 2003; 116: U383–392
   PubMedGoogle Scholar
• World Health Organization. Worldwide amphetamine abuse- “a particular concern for WHO”: World Health Organization press release WHO/77 Rev. World Health Organization, Geneva 13 November, 1996, 1996
   Google Scholar
• Wu L-T, Schlenger WE, Galvin DM. Concurrent use of methamphetamine, MDMA, LSD, Ketamine, GHB, and flunitrazepam among American youths. Drug and Alcohol Dependence 2006; 84: 102–113
   PubMed Web of Science ®Google Scholar
• Yacoubian JS. Assessing the temporal relationship between race and ecstasy use among high school seniors. Journal of Drug Education 2002; 32(2)213–225
   PubMedGoogle Scholar
• Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood. II Sequences of progression. American Journal of Public Health 1984; 74: 668–72
   PubMed Web of Science ®Google Scholar
• Zimmerman P, Wiottchen HU, Waszak F, Hofler M, Leib R. Pathways into ecstasy use: The role of prior cannabis use and ecstasy availability. Drug and Alcohol Dependence 2005; 79(3)331–341
   PubMed Web of Science ®Google Scholar